为进一步加强与投资者的互动交流，贤丰控股股份有限公司（以下简称"公 司"）将参加由中国证券监督管理委员会广东监管局和广东上市公司协会联合举 办的"向新提质 价值领航——2025 年广东辖区投资者集体接待日暨辖区上市公 司中报业绩说明会"活动，现将相关事项公告如下： 本次活动将采用网络远程的方式举行，投资者可登录"全景•路演天下"网站 （http://rs.p5w.net）参与本次互动交流。本次活动时间为 2025 年 9 月 19 日（星 期五）15:30-17:00。届时公司高管将在线就公司业绩情况、公司治理、发展战略、 经营状况等投资者关心的问题，与广大投资者作集中说明、互动交流，欢迎广大 投资者积极参与！ 证券代码：002141 证券简称：贤丰控股 公告编号：2025-072 贤丰控股股份有限公司 关于参加广东辖区 2025 年投资者 网上集体接待日活动的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 特此公告。 贤丰控股股份有限公司 董事会 2025 年 9 月 16 日 ...

Core Insights - The animal health sector experienced a 1.14% increase on September 15, with BioShares leading the gains [1] - The Shanghai Composite Index closed at 3860.5, down 0.26%, while the Shenzhen Component Index closed at 13005.77, up 0.63% [1] Stock Performance - BioShares (600201) closed at 8.82, up 7.17% with a trading volume of 624,100 shares and a turnover of 539 million yuan [1] - Dayu Biological (871970) closed at 11.50, up 6.09% with a trading volume of 124,300 shares and a turnover of 139 million yuan [1] - Other notable performers include: - Jinhai Biological (002688) at 7.20, up 3.00% [1] - Ruipu Biological (300119) at 21.98, up 1.76% [1] - Zhongmu Co. (600195) at 7.50, up 1.63% [1] Capital Flow - The animal health sector saw a net outflow of 25.577 million yuan from institutional investors, while retail investors contributed a net inflow of 6.5625 million yuan [2] - The capital flow for individual stocks indicates: - Jinhai Biological had a net inflow of 32.1651 million yuan from institutional investors [3] - Zhongmu Co. had a net inflow of 6.8986 million yuan from institutional investors [3] - Ruipu Biological experienced a net outflow of 1.1475 million yuan from institutional investors [3]

证券日报网讯 9月12日晚间，贤丰控股发布公告称，董事会近日收到公司证券事务代表温秋萍女士的书 面辞职报告。温秋萍女士因个人原因辞去公司证券事务代表职务。辞职后，温秋萍女士不再担任公司任 何职务。温秋萍女士的辞职报告自送达公司董事会之日起生效。 （文章来源：证券日报） ...

证券代码：002141 证券简称：贤丰控股 公告编号：2025-071 贤丰控股股份有限公司 关于证券事务代表辞职的公告 温秋萍女士已完成所负责相关工作的交接，其辞职不会对公司相关工作及生 产经营产生影响。公司将按照相关规定，尽快聘任符合任职资格的人员担任证券 事务代表，协助董事会秘书开展工作。 特此公告。 贤丰控股股份有限公司 董事会 2025 年 9 月 12 日 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 贤丰控股股份有限公司（以下简称"公司"）董事会近日收到公司证券事务 代表温秋萍女士的书面辞职报告。温秋萍女士因个人原因辞去公司证券事务代表 职务。辞职后，温秋萍女士不再担任公司任何职务。温秋萍女士的辞职报告自送 达公司董事会之日起生效。截至本公告日，温秋萍女士未持有公司股份。 公司及公司董事会对温秋萍女士任职期间的勤勉工作及对公司发展作出的贡 献表示衷心感谢！ ...

Market Overview - The animal health sector experienced a decline of 0.21% on September 12, with Dayu Biological leading the drop [1] - The Shanghai Composite Index closed at 3883.69, up 0.22%, while the Shenzhen Component Index closed at 12996.38, up 0.13% [1] Individual Stock Performance - Shunlian Biological (688098) closed at 11.85, up 2.07% with a trading volume of 85,100 shares and a turnover of 99.05 million yuan [1] - KQ Biological (688526) closed at 18.63, up 0.70% with a trading volume of 19,700 shares and a turnover of 36.27 million yuan [1] - Huisheng Biological (300871) closed at 22.55, up 0.53% with a trading volume of 54,100 shares and a turnover of 122 million yuan [1] - Dayu Biological (871970) led the decline, closing at 10.73, down 3.85% with a trading volume of 76,600 shares and a turnover of 82.31 million yuan [2] Capital Flow Analysis - The animal health sector saw a net outflow of 15.44 million yuan from institutional investors, while retail investors experienced a net outflow of 9.04 million yuan [2] - Speculative funds recorded a net inflow of 24.47 million yuan [2] Detailed Capital Flow for Selected Stocks - Shunlian Biological had a net inflow of 14.94 million yuan from institutional investors, but a net outflow of 21.09 million yuan from retail investors [3] - Huisheng Biological experienced a net outflow of 7.83 million yuan from institutional investors, while retail investors had a net inflow of 9.81 million yuan [3] - KQ Biological saw a net outflow of 1.73 million yuan from institutional investors, with a minor net inflow from retail investors [3]

Core Viewpoint - The animal health sector experienced a rise of 0.92% on September 11, with Dayu Biological leading the gains, while the overall market indices also showed significant increases [1]. Group 1: Market Performance - The Shanghai Composite Index closed at 3875.31, up 1.65%, and the Shenzhen Component Index closed at 12979.89, up 3.36% [1]. - Dayu Biological's stock price increased by 3.81% to 11.16, with a trading volume of 140,500 shares and a transaction value of 158 million [1]. Group 2: Individual Stock Performance - Other notable performers included: - Houfeng Holdings, up 2.75% to 4.11, with a trading volume of 326,800 shares and a transaction value of 133 million [1]. - Keqian Biological, up 2.15% to 18.50, with a trading volume of 32,400 shares and a transaction value of 59.27 million [1]. - Yongshun Biological, up 1.69% to 10.80, with a trading volume of 48,100 shares and a transaction value of 52.46 million [1]. Group 3: Capital Flow Analysis - The animal health sector saw a net outflow of 70.71 million from institutional investors, while retail investors contributed a net inflow of 77.65 million [2][3]. - The capital flow for individual stocks showed varied trends, with significant outflows from stocks like Zhongmu Co., which had a net outflow of 11.86 million from institutional investors [3].

Meeting Details - The meeting was held on September 5, 2025, at 15:00, with online voting available from 9:15 to 11:30 on the same day [1] - A total of 3 shareholders attended the meeting in person, representing 117,310,747 shares (14.2917% of total voting shares), while 341 shareholders participated via online voting, representing 5,694,900 shares (0.6938% of total voting shares) [1][2] Voting Results - The total voting results showed that 122,292,647 shares were in favor of the proposals, accounting for 99.4204% of the valid votes cast [2] - Among small shareholders, 4,982,000 shares voted in favor, representing 87.4802% of the small shareholder votes [3] - The overall voting results indicated that 122,323,047 shares were in favor, which is 99.4451% of the valid votes [4] Legal Compliance - The meeting was witnessed by lawyers from Shanghai Jintiancheng (Shenzhen) Law Firm, who confirmed that the meeting's procedures and voting processes complied with relevant laws and regulations [11]

Core Viewpoint - The legal opinion letter confirms that the convening and holding of the 2025 Second Extraordinary General Meeting of Shareholders of Xianfeng Holdings Co., Ltd. complies with relevant laws and regulations, ensuring the legitimacy and validity of the meeting and its resolutions [1][14]. Group 1: Meeting Organization - The meeting was convened by the company's board of directors, with the decision made on August 19, 2025 [2][3]. - The notice for the meeting was published on August 21, 2025, meeting the requirement of being announced at least 15 days prior to the meeting date [3]. Group 2: Attendance and Voting - A total of 344 shareholders and their proxies attended the meeting, representing 123,005,647 shares, which is 14.9855% of the total voting shares [5]. - Among the attendees, 3 shareholders represented 117,310,747 shares, accounting for 14.2917% of the total shares [5]. - The meeting utilized both on-site and online voting methods, with online voting available from 9:15 AM to 3:00 PM on September 5, 2025 [3][4]. Group 3: Voting Results - The voting results indicated that the first and second items on the agenda were passed with significant support, with 122,292,647 shares voting in favor, representing a majority of the votes cast [7]. - The small investors' voting results showed that 87.4802% of the small shareholders voted in favor of the proposals [7]. - The voting process was conducted in accordance with legal requirements, and all resolutions were deemed valid [14].

Group 1 - The company held the 20th meeting of the 8th Board of Directors on August 19, 2025, and the second extraordinary general meeting of shareholders on September 5, 2025, where several proposals were approved, including changes to the registered address and business scope, as well as amendments to the company's articles of association and various management systems [1][2] - The company no longer has a supervisory board, and the responsibilities of the supervisory board have been transferred to the audit committee of the board of directors [2] - The company expressed gratitude to the former supervisors for their contributions to the company's development during their tenure [2]

证券代码：002141 证券简称：贤丰控股 公告编号：2025-070 贤丰控股股份有限公司 关于公司制度修订及制定已生效的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 贤丰控股股份有限公司（以下简称"公司"）分别于 2025 年 8 月 19 日召开 第八届董事会第二十次会议、2025 年 9 月 5 日召开 2025 年第二次临时股东大会 审议通过了《关于变更注册地址和经营范围并修订<公司章程>的议案》、《关 于修订公司部分制度的议案》、《董事、高级管理人员薪酬管理制度》（2025 年 8 月），同意公司修订部分制度及制定制度，公司不再设置监事会，公司 2025 年 8 月 21 日在巨潮资讯网（www.cninfo.com.cn）披露的下列制度已生效：《公司 章程》（2025 年 8 月）、《董事会议事规则》（2025 年 8 月）、《股东会议事 规则》（2025 年 8 月）、《募集资金管理制度》（2025 年 8 月）、《对外投资 管理制度》（2025 年 8 月）、《独立董事工作制度》（2025 年 8 月）、《关联 交易决策制度》（202 ...